StockTipsArenaBeta

Natco Pharma Share price target & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹784.45-16.40 (-2.05%)
As of 21 Oct 2026

Only one active 1–3 month target

The short-term call is BUY

₹8204.5% above today's price

Natco Pharma has one active 1–3 month share price target: ₹820 from Laxmikant Shukla, YES Securities (19 Oct 2026). One target is a single view, not a consensus.

1
1 BUY · 0 SELL, all horizons
1
with an active 1–3M target
N/A
9 of 10 closed calls needed
10
all horizons, open and closed
Watch NATCOPHARM for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

All tips (10)

BUYTarget₹1,250
ISbyICICI SecuritiesTarget hit
1 Year* · 30 May 2024 · entry ₹1,020.3 · via Institutional / Brokerage Researchexit ₹1,250
BUYTarget₹1,675
ISbyICICI SecuritiesExpired
1 Year* · 7 Oct 2024 · entry ₹1,401.65 · via Institutional / Brokerage Researchexit ₹811.4
BUYTarget₹820
LSbyLaxmikant Shukla, YES Securities+4.5% to target
1–3 Months · 3 mo left · 19 Oct 2026 · entry ₹794.7 · via NDTV ProfitP&L -1.3%
BUYTarget₹950
PHbyPradeep Haldar, PHD CapitalTarget hit
1–3 Months · 12 Jun 2026 · entry ₹852.8 · via Business Todayexit ₹950
BUYTarget₹1,325
ICbyIDBI CapitalStop-loss hit
1–3 Months · 14 May 2026 · entry ₹1,208 · via IDBI Capital Research Calls Telegramexit ₹1,155
BUYTarget₹1,150
DDbyDhupesh Dhameja, SAMCO SecuritiesStop-loss hit
1–3 Months · 30 Mar 2026 · entry ₹1,000 · via CNBC Awaaz.exit ₹972
BUYTarget₹1,025
ASbyAmit SethTarget hit
1–2 Weeks* · 27 Mar 2026 · entry ₹978 · via CNBC Awaaz.exit ₹1,025
BUYTarget₹1,000
PGbyPrakash GabaStop-loss hit
1–2 Weeks* · 13 Aug 2026 · entry ₹946.55 · via CNBC Awaaz.exit ₹930
BUYTarget₹1,000
PGbyPrakash GabaStop-loss hit
1–2 Weeks* · 7 Jul 2026 · entry ₹976 · via CNBC Awaaz.exit ₹960
BUYTarget₹1,010
ICbyIDBI CapitalExpired
1–2 Weeks* · 7 Jul 2026 · entry ₹965 · via IDBI Capital Research Calls Telegramexit ₹949.85

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks